Patient-centric trials for therapeutic development in precision oncology.
about
Gene aberrations for precision medicine against lung adenocarcinomaEnvironmental Chemical Assessment in Clinical Practice: Unveiling the Elephant in the RoomIntegrating next-generation sequencing into clinical oncology: strategies, promises and pitfallsUsing Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer TherapyDynamic Consent: a potential solution to some of the challenges of modern biomedical research.Precision oncology based on omics data: The NCT Heidelberg experience.Development of the Theta Comparative Cell Scoring Method to Quantify Diverse Phenotypic Responses Between Distinct Cell Types.MediBoost: a Patient Stratification Tool for Interpretable Decision Making in the Era of Precision MedicineFrom Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic CancersLeveraging Genomic Factors to Improve Benefit-Risk.Identification of a gene expression profile associated with the regulation of angiogenesis in endometrial cancer.Optimizing drug development in oncology by clinical trial simulation: Why and how?Novel translational therapeutic strategy by sequencing primary liver cancer genomes.Innovative Clinical Trial Designs for Precision Medicine in Heart Failure with Preserved Ejection Fraction.The impact of structural biology in medicine illustrated with four case studies.The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer.Entropy-based Consensus Clustering for Patient Stratification.Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality.The burden of proof: The current state of atrial fibrillation prevention and treatment trials.The cost of molecular-guided therapy in oncology: a prospective cost study alongside the MOSCATO trial.Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?Functional exploration of colorectal cancer genomes using Drosophila.3q26-29 Amplification in head and neck squamous cell carcinoma: a review of established and prospective oncogenes.Large-scale computational models of liver metabolism: How far from the clinics?Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic CancerMutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center.Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients; Utility of Targeted Deep Sequencing for Biomarker-Selected Clinical Trial.Baseline HBsAg and HBcrAg titres allow peginterferon-based 'precision medicine' in HBeAg-negative chronic hepatitis B patients.Covalent, Non-Covalent, Encapsulated Nanodrug Regulate the Fate of Intra- and Extracellular Trafficking: Impact on Cancer and Normal Cells.Debunking the Delusion That Precision Oncology Is an Illusion.MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer.Precision oncology: neither a silver bullet nor a dream.Evidence-Based Precision Oncology with the Cancer Targetome.New challenges to psycho-oncology research: Precision medicine oncology and targeted therapies.The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities.Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology.Nuclear Medicine in the Era of Precision Medicine.Prediction of pancreatic cancer risk and therapeutic response with next-generation sequencing.Clonality in context: hematopoietic clones in their marrow environment.Pharmacogenomics: Time to re-think its role in Precision Medicine.
P2860
Q26749348-76941A9B-6C7C-4473-9E6B-D9BAA19CF3B4Q26768636-564092CE-C2DB-425E-8C3C-22D18443E845Q28066709-D42D3F29-6E7A-4BFD-B5E7-E5978697BD1CQ28076097-D9523978-A47A-49C1-8403-AE92C98BB41FQ36260402-2F29F9A3-63C3-4236-967C-3FF9231F752FQ36396606-EA38318A-2B4F-4AAD-B788-0F2EA465AE19Q37240862-BDE208DF-A56E-4A35-88FF-D1F0957E1D47Q37454743-9B4FB664-EF4B-41D2-9358-F08E8EDDC993Q37631655-4FFA3EBA-7725-4C4F-8DDC-16C8A5EBE784Q37708018-82D7C289-9681-4A85-93CA-12F2CDF8666DQ38665853-4EC29CA6-D23C-40B3-AA03-46FFF816A411Q38675644-3C5A58BD-A01E-4015-931A-F9128B2D47A0Q38685397-00481AF5-DB4A-4458-AF76-D5492ED4217AQ38691846-DB5395CA-6B1D-4A12-BC22-2365F092CE39Q38698199-A6F9252F-C619-48B9-8471-E213257AE6B3Q38824065-50F4E295-4990-42EA-AF69-09DC45AF8DCBQ38860341-1FDE85E8-1B19-45F9-B104-2E3B3F1975E4Q38909404-9051E390-3071-4C10-ABB0-CCE1965329DCQ39119910-463BD828-76D6-4B91-B674-DD6DD281388CQ39139865-23082520-9D9B-4CC6-ADC8-D5AAED1CDD39Q39142265-10647A53-65C0-4083-B895-612BB55CEE72Q39145987-A32FEDE8-1C5E-4DEF-A255-1281BBD3528BQ39186868-380426F1-F5FF-468D-A7A4-43EE69D8FA4FQ39315101-3480A8F0-AAC5-42BE-8F8D-9457A42322F0Q39515411-B933E38F-699F-41BA-9D94-83C894AAB013Q40077046-C3635F23-0857-4255-BF81-FD9AF8454A7FQ40125226-5E93E22B-7E3C-4E2A-A924-9C822B3877D0Q40499021-E1F39AD2-E9D6-4F08-AAAA-F19740D78FF2Q41123555-A181E72B-819F-4C9C-8A5D-5772DA86ED17Q46539715-CF25DDCF-43F6-4FFC-BCB2-834DAF44833BQ47664260-753BAD24-21B1-405F-98F0-03601BF8E479Q47737073-ED6D8713-D77B-405B-965A-6854F8F37726Q47893147-2B73A26E-55E7-4AC4-BA61-9D3722B97862Q47987953-7ECFD9D2-7E68-4350-B19F-4513DD6A80B8Q48098689-1ACAB7ED-633F-4846-8185-59C549AB1091Q48335581-FEC76C61-AEA0-4973-ACF2-4B7A66667E1AQ48354666-D553EDC6-24AE-41F4-A3F6-B6260955D52FQ49858111-308DDDF6-18F2-479C-B3FA-E8C4CBFB8230Q50091222-FBBF05A9-77CE-4D68-9FD7-C807E77A663DQ50147809-7BF83A0B-70D9-48CD-B756-7309CCAD8E8C
P2860
Patient-centric trials for therapeutic development in precision oncology.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Patient-centric trials for therapeutic development in precision oncology.
@en
type
label
Patient-centric trials for therapeutic development in precision oncology.
@en
prefLabel
Patient-centric trials for therapeutic development in precision oncology.
@en
P2860
P356
P1433
P1476
Patient-centric trials for therapeutic development in precision oncology
@en
P2093
Simon J Hollingsworth
P2860
P2888
P304
P356
10.1038/NATURE15819
P407
P577
2015-10-01T00:00:00Z
P6179
1027337054